Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

1984 • 4,180 citations

An Immunohistochemical Study

1989 • 1,928 citations

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

1992 • 1,484 citations

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

1993 • 777 citations

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1992 • 757 citations

P53 expression in breast cancer

1988 • 612 citations

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

1992 • 530 citations

Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients

1992 • 349 citations

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1989 • 267 citations

Ki-67 immunostaining in human breast tumors and its relationship to prognosis

1991 • 258 citations

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1986 • 249 citations

The long‐term prognostic significance of the thymidine labelling index in breast cancer

1984 • 225 citations

Association of MMP-2 Activation Potential With Metastatic Progression in Human Breast Cancer Cell Lines Independent of MMP-2 Production

1993 • 216 citations

Cell kinetics as a prognostic marker in node-negative breast cancer

1985 • 197 citations

Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel “paraffin”-reactive MIB1 antibody

1994 • 191 citations

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival

1995 • 183 citations

Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.

1991 • 182 citations

Proliferation index as a prognostic marker in breast cancer

1993 • 181 citations

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1991 • 172 citations

Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells.

1989 • 164 citations

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer

1987 • 145 citations

Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

1994 • 140 citations

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

1987 • 128 citations

Vimentin—a new prognostic parameter in breast carcinoma?

1989 • 117 citations

Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.

1990 • 111 citations

P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1994 • 102 citations

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1993 • 101 citations

Epidermal growth factor receptor expression as a prognostic indicator in breast cancer

1991 • 100 citations

Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.

1990 • 93 citations

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

1993 • 92 citations

Quantitative Growth Fraction Evaluation with MIB1 and Ki67 Antibodies in Breast Carcinomas

1994 • 90 citations

Oncogene-induced basement membrane invasiveness in human mammary epithelial cells

1994 • 83 citations

Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences

1993 • 69 citations

Abnormalp53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1992 • 66 citations

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67

1991 • 55 citations

Pathological and biological features of mammographically detected invasive breast carcinomas

1995 • 55 citations

Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival.

1992 • 50 citations

Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer

1992 • 47 citations

Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.

1993 • 46 citations

The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status.

1991 • 45 citations

p53 protein and vimentin m invasive ductal NOS breast carcinoma—relationship with survival and sites of metastases

1994 • 41 citations

K-67 Immunoreactivity in Breast Carcinomas in Relation to Transferrin Receptor Expression, Estrogen Receptor Status and Morphological Criteria

1989 • 31 citations

A negative regulatory factor is missing in a human metastatic breast cancer cell line.

1994 • 25 citations

Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer.

1994 • 17 citations

Evaluation of integrated morpho-biological indicators in breast cancer.

1993 • 3 citations